NOVEL UREA 6,7-DIHYDRO-4H-THIAZOLE[5,4-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
申请人:AICURIS GMBH & CO. KG
公开号:US20220009945A1
公开(公告)日:2022-01-13
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.